Inogen Inc (INGN) stock
INGNNasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 11/3068% below fair value
$5.57−0.11 (-2.02%)
Close on Nov 18, 2026Market cap $147.82MP/E –Yield –
Inogen operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Inogen's operating income for the twelve months ending Jun 30, 2026 was -$30.85M. For fiscal 2025 it was -$30.21M. The highest annual figure on record is $37.89M in fiscal 2018.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$30.21M | – |
| FY2024 | Dec 31, 2024 | -$42.52M | – |
| FY2023 | Dec 31, 2023 | -$109.39M | – |
| FY2022 | Dec 31, 2022 | -$85.24M | -1022.5% |
| FY2021 | Dec 31, 2021 | $9.24M | – |
| FY2020 | Dec 31, 2020 | -$12.03M | -160.8% |
| FY2019 | Dec 31, 2019 | $19.79M | -47.8% |
| FY2018 | Dec 31, 2018 | $37.89M | +37.3% |
| FY2017 | Dec 31, 2017 | $27.59M | +20.7% |
| FY2016 | Dec 31, 2016 | $22.86M | +51.9% |
| FY2015 | Dec 31, 2015 | $15.05M | +43.2% |
| FY2014 | Dec 31, 2014 | $10.51M | +135.5% |
| FY2013 | Dec 31, 2013 | $4.46M | +438.5% |
| FY2012 | Dec 31, 2012 | $829.00K | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$5.10M | – |
| Q1 FY2026 | Mar 31, 2026 | -$9.34M | – |
| Q4 FY2025 | Dec 31, 2025 | -$9.31M | – |
| Q3 FY2025 | Sep 30, 2025 | -$7.12M | – |
| Q2 FY2025 | Jun 30, 2025 | -$6.13M | – |
| Q1 FY2025 | Mar 31, 2025 | -$7.66M | – |
| Q4 FY2024 | Dec 31, 2024 | -$11.39M | – |
| Q3 FY2024 | Sep 30, 2024 | -$7.79M | – |
| Q2 FY2024 | Jun 30, 2024 | -$7.06M | – |
| Q1 FY2024 | Mar 31, 2024 | -$16.27M | – |
| Q4 FY2023 | Dec 31, 2023 | -$28.98M | – |
| Q3 FY2023 | Sep 30, 2023 | -$46.72M | – |
| Q2 FY2023 | Jun 30, 2023 | -$11.77M | – |
| Q1 FY2023 | Mar 31, 2023 | -$21.92M | – |
| Q4 FY2022 | Dec 31, 2022 | -$58.49M | – |
| Q3 FY2022 | Sep 30, 2022 | -$10.29M | -261.5% |
| Q2 FY2022 | Jun 30, 2022 | -$2.88M | -124.6% |
| Q1 FY2022 | Mar 31, 2022 | -$13.59M | – |
| Q4 FY2021 | Dec 31, 2021 | -$6.67M | – |
| Q3 FY2021 | Sep 30, 2021 | $6.37M | – |
| Q2 FY2021 | Jun 30, 2021 | $11.67M | – |
| Q1 FY2021 | Mar 31, 2021 | -$2.13M | – |
| Q4 FY2020 | Dec 31, 2020 | -$5.52M | – |
| Q3 FY2020 | Sep 30, 2020 | -$1.97M | -124.3% |
| Q2 FY2020 | Jun 30, 2020 | -$2.35M | -119.4% |
| Q1 FY2020 | Mar 31, 2020 | -$2.18M | -144.9% |
| Q4 FY2019 | Dec 31, 2019 | -$5.32M | -211.4% |
| Q3 FY2019 | Sep 30, 2019 | $8.11M | -22.0% |
| Q2 FY2019 | Jun 30, 2019 | $12.15M | -13.4% |
| Q1 FY2019 | Mar 31, 2019 | $4.86M | -44.2% |
| Q4 FY2018 | Dec 31, 2018 | $4.78M | -8.0% |
| Q3 FY2018 | Sep 30, 2018 | $10.40M | +24.8% |
| Q2 FY2018 | Jun 30, 2018 | $14.02M | +65.0% |
| Q1 FY2018 | Mar 31, 2018 | $8.70M | +56.2% |
| Q4 FY2017 | Dec 31, 2017 | $5.19M | -15.9% |
| Q3 FY2017 | Sep 30, 2017 | $8.33M | +54.4% |
| Q2 FY2017 | Jun 30, 2017 | $8.50M | – |
| Q1 FY2017 | Mar 31, 2017 | $5.57M | – |
| Q4 FY2016 | Dec 31, 2016 | $6.17M | – |
| Q3 FY2016 | Sep 30, 2016 | $5.40M | – |
See a number that looks wrong?